MedEquities Realty Trust Inc (NYSE:MRT) – Equities research analysts at B. Riley raised their FY2019 EPS estimates for MedEquities Realty Trust in a report issued on Thursday. B. Riley analyst B. Maher now expects that the financial services provider will earn $1.31 per share for the year, up from their prior forecast of $1.30. B. Riley has a “Buy” rating and a $13.00 price target on the stock.
A number of other brokerages have also weighed in on MRT. ValuEngine upgraded shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, December 1st. Zacks Investment Research lowered shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $14.00 price objective on shares of MedEquities Realty Trust in a report on Wednesday, February 21st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $13.00.
MedEquities Realty Trust (NYSE:MRT) last released its earnings results on Wednesday, February 21st. The financial services provider reported $0.18 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.31 by ($0.13). MedEquities Realty Trust had a net margin of 34.96% and a return on equity of 5.99%. The business had revenue of $16.23 million for the quarter, compared to analysts’ expectations of $16.31 million. During the same quarter in the previous year, the business posted ($0.06) earnings per share. MedEquities Realty Trust’s revenue for the quarter was up 13.8% on a year-over-year basis.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. LSV Asset Management purchased a new position in MedEquities Realty Trust in the 4th quarter worth approximately $103,000. JPMorgan Chase & Co. bought a new stake in MedEquities Realty Trust in the 3rd quarter worth approximately $118,000. MetLife Investment Advisors LLC bought a new stake in MedEquities Realty Trust in the 4th quarter worth approximately $120,000. Raymond James Financial Services Advisors Inc. bought a new stake in MedEquities Realty Trust in the 2nd quarter worth approximately $154,000. Finally, Alliancebernstein L.P. bought a new stake in MedEquities Realty Trust in the 2nd quarter worth approximately $175,000. Institutional investors own 90.57% of the company’s stock.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 5th. Investors of record on Monday, February 19th will be issued a $0.21 dividend. The ex-dividend date is Thursday, February 15th. This represents a $0.84 dividend on an annualized basis and a yield of 8.43%. MedEquities Realty Trust’s payout ratio is currently 131.25%.
MedEquities Realty Trust Company Profile
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.